
Leaving FDA, Califf is unapologetic — and warns of staff departures
In a wide-ranging interview, Robert Califf, the departing commissioner of the Food and Drug Administration, defended the FDA’s record under his leadership, praised the progress
In a wide-ranging interview, Robert Califf, the departing commissioner of the Food and Drug Administration, defended the FDA’s record under his leadership, praised the progress
It’s easy to forget that we live in an age of medical wonders. Cancer tumors can be slowed or shrunk in ways previous generations couldn’t
President-elect Donald Trump suggested in a television interview on Sunday that he shares some of the concerns voiced by Robert F. Kennedy Jr., his choice
Eli Lilly said its weight loss drug Zepbound led to 47% greater weight reduction than rival medicine Wegovy, made by Novo Nordisk, in a head-to-head
If there is a message in President-elect Trump’s Friday night reveal of who he intends to nominate for key health care positions in his administration,
What happens when the Trump train hits the health care establishment? There’s no doubt that President-elect Trump’s decision to nominate Robert F. Kennedy Jr., an
Pfizer said its chief oncology officer, Chris Boshoff, will head all of the company’s research and development efforts in addition to keeping his current duties
Merck said a new formulation of the best-selling drug, Keytruda, appears to deliver similar blood levels of the medicine when it is given as a
WASHINGTON — Peter Marks wants to keep his job. A top Food and Drug Administration official, Marks arrived Wednesday at the five-star hotel where the Milken
23andMe, the genetics startup that has repeatedly captured the public imagination and then faced nearly fatal business challenges, announced Monday that it would halt its